Diabet Med

1. COMMISSARIAT PV, DiMeglio LA, Kanapka LG, Laffel LM, et al
   Twelve-month Psychosocial Outcomes of Continuous Glucose Monitoring with Behavioral Support in Parents of Young Children with Type 1 Diabetes.
   Diabet Med. 2023 Apr 21:e15120. doi: 10.1111/dme.15120.
   

   >> Share

   
   
2. EMBAYE J, Bassi G, Dingemans AE, Doesborg L, et al
   Associations between disordered eating behaviour, diabetes distress and emotion regulation strategies in adults with type 1 diabetes: results from a Dutch-Italian cross-sectional study.
   Diabet Med. 2023 Apr 20:e15122. doi: 10.1111/dme.15122.
   

   >> Share

   
   
3. DESHMUKH H, Adeleke KA, Ssemmondo E, Wilmot EG, et al
   Ethnic disparities in people accessing Free-Style Libre in the United Kingdom: Insights from the Association of British Clinical Diabetologists audit.
   Diabet Med. 2023 Mar 30:e15095. doi: 10.1111/dme.15095.
   

   >> Share

   
   
4. THOMSON I, Anderson N, Bath L, Kiff S, et al
   Type 1 diabetes incidence in Scotland between 2006 and 2019.
   Diabet Med. 2023 Feb 14:e15069. doi: 10.1111/dme.15069.
   

   >> Share

   
   

   
   Intern Med

5. KUNO M, Sawa N, Mizuno H, Oba Y, et al
   Immunoglobulin G4-related Hepatopathy after COVID-19 Vaccination.
   Intern Med. 2023;62:2139-2143.
   

   >> Share

   
   
6. TSUKAMOTO Y, Sugimoto T, Umeda M, Kato T, et al
   A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies.
   Intern Med. 2023;62:2145-2149.
   

   >> Share

   
   
7. NAKAMURA J, Nagashima T, Yazawa H, Kokuzawa A, et al
   Perihepatitis as an Initial Manifestation of Systemic Lupus Erythematosus.
   Intern Med. 2023 Jul 19. doi: 10.2169/internalmedicine.2165.
   

   >> Share

   
   

   
   J Clin Endocrinol Metab

8. AJIE M, van Heck JIP, Janssen AWM, Meijer RI, et al
   Disease duration and chronic complications associate with immune activation in individuals with longstanding type 1 diabetes.
   J Clin Endocrinol Metab. 2023 Feb 17:dgad087. doi: 10.1210.
   

   >> Share

   
   

   
   J Neuroimmunol

9. PRIEGO M, Noriega L, Kalinin S, Hoffman LM, et al
   Genetic deletion of c-Jun amino-terminal kinase 3 (JNK3) modestly increases disease severity in a mouse model of multiple sclerosis.
   J Neuroimmunol. 2023;382:578152.
   

   >> Share

   
   
10. WANG R, Sun DR, Du Q, Zhang Y, et al
    Serum antinuclear antibodies associate with severe disease activity in neuromyelitis optica spectrum disorder.
    J Neuroimmunol. 2023;382:578151.
    

    >> Share

    
    

    
    J Neurol

11. LOMBARDO-DEL TORO P, Bragado-Trigo I, Arroyo P, Tena-Cucala R, et al
    Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim.
    J Neurol. 2023 Jul 17. doi: 10.1007/s00415-023-11865.
    

    >> Share

    
    
12. ROCCA MA, Valsasina P, Lamanna MT, Colombo B, et al
    Functional connectivity modifications in monoaminergic circuits occur in fatigued MS patients treated with fampridine and amantadine.
    J Neurol. 2023 Jul 18. doi: 10.1007/s00415-023-11858.
    

    >> Share

    
    
13. NOTEBOOM S, van Nederpelt DR, Bajrami A, Moraal B, et al
    Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR.
    J Neurol. 2023 Jul 19. doi: 10.1007/s00415-023-11870.
    

    >> Share

    
    
14. AL-ANI A, Chen JJ, Costello F
    Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges.
    J Neurol. 2023;270:4132-4150.
    

    >> Share

    
    

    
    Lancet

15. 
    Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2023 Jun 22:S0140-6736(23)01301-6. doi: 10.1016/S0140-6736(23)01301.
    

    >> Share

    
    

    
    Mult Scler

16. COHEN JA
    Commentary: Solomon AJ et al. Differential diagnosis of suspected multiple sclerosis: An updated consensus approach. Lancet Neurol (in press).
    Mult Scler. 2023 Jul 20:13524585231188097. doi: 10.1177/13524585231188097.
    

    >> Share

    
    

    
    Neurology

17. LONGBRAKE E, Kalincik T
    Early Treatment for Multiple Sclerosis: Time Is Brain.
    Neurology. 2023 Jul 19:10.1212/WNL.0000000000207754.
    

    >> Share

    
    
18. EHRHARDT H, Lambe J, Moussa H, Vasileiou ES, et al
    Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post-Hoc Analyses of the SPRINT-MS Trial.
    Neurology. 2023 Jul 17:10.1212/WNL.0000000000207551.
    

    >> Share

    
    
19. HOSHINA Y, Wright MA, Warner JE, Richards T, et al
    Pearls & Oy-sters: ATX-FGF14 Mimicking Autoimmune Pathology.
    Neurology. 2023 Jul 17:10.1212/WNL.0000000000207590.
    

    >> Share

    
    
20. BENNETT JL
    Sprinting to the Finish: Optical Coherence Tomography, Retinal Atrophy, and Neurodegeneration in Progressive Multiple Sclerosis.
    Neurology. 2023 Jul 17:10.1212/WNL.0000000000207607.
    

    >> Share

    
    

    
    PLoS One

21. NAISBY J, Wilson-Menzfeld G, Baker K, Morris R, et al
    Yoga and Multiple Sclerosis: Maintaining engagement in physical activity.
    PLoS One. 2023;18:e0288319.
    

    >> Share

    
    
22. VIATCHENKO-KARPINSKI V, Kong L, Weng HR
    Deficient AMPK activity contributes to hyperexcitability in peripheral nociceptive sensory neurons and thermal hyperalgesia in lupus mice.
    PLoS One. 2023;18:e0288356.
    

    >> Share

    
    
23. VILADES E, Cordon B, Perez-Velilla J, Orduna E, et al
    Evaluation of multiple sclerosis severity using a new OCT tool.
    PLoS One. 2023;18:e0288581.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

24. CANTOR H
    Renegade T cell clones and autoimmune disease.
    Proc Natl Acad Sci U S A. 2023;120:e2310236120.
    

    >> Share

    
    
25. SAGAN SA, Moinfar Z, Moseley CE, Dandekar R, et al
    T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity.
    Proc Natl Acad Sci U S A. 2023;120:e2306572120.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share